Table 2 Summary of clinicopathological data of meningioma patients
Parameter | No. | CD44 | MMP-9 | Ki67% | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
Mean ± SD | Median (IQR) | p value | Mean ± SD | Median (IQR) | p value | Mean ± SD | Median (IQR) | p value | ||
Age group | ||||||||||
• < 50 years | 24 | 3.83 ± 1.1 | 4 (2) | = 0.935 | 4.50 ± 1.6 | 5 (3) | = 0.261 | 8.45 ± 7.9 | 6 (5) | = 0.115 |
• ≥ 50 years | 26 | 3.85 ± 1.1 | 4 (1) | 4.04 ± 1.6 | 4 (2) | 5.51 ± 4.8 | 4 (4) | |||
Sex | ||||||||||
• Female | 41 | 3.80 ± 1.1 | 4 (2) | = 0.356 | 4.20 ± 1.5 | 5 (3) | = 0.402 | 6.55 ± 6.2 | 5 (5) | = 0.026* |
• Male | 9 | 4.00 ± 0.7 | 4 (1) | 4.56 ± 1.9 | 5 (2) | 8.60 ± 6.1 | 13 (11) | |||
Grade | ||||||||||
• G I | 32 | 3.38 ± 0.9 | 3 (1) | < 0.001** | 3.81 ± 1.5 | 4 (2) | < 0.001** | 3.28 ± 2.2 | 3 (3) | < 0.001** |
• G II–III | 18 | 4.67 ± 0.8 | 4 (1) | 5.06 ± 1.4 | 5.5 (1) | 13.89 ± 6.8 | 14 (10) | |||
Simpson grade | ||||||||||
• I | 10 | 3.40 ± 1.4 | 3 (1) | = 0.026* | 3.80 ± 1.9 | 3.5 (2) | = 0.527 | 7.80 ± 6.7 | 3 (3) | = 0.845 |
• II | 36 | 3.89 ± 1.0 | 4 (1) | 4.42 ± 1.5 | 5 (3) | 6.58 ± 5.4 | 6 (5.5) | |||
• III–IV | 4 | 4.50 ± 0.6 | 4.5 (1) | 4.00 ± 1.2 | 4 (2) | 7.80 ± 5.2 | 8 (7) | |||